Vaskulær endotelial vækstfaktor-terapi ved iskæmisk hjertesygdom.

Translated title of the contribution: Vascular endothelial growth factor therapy in ischaemic heart disease
3 Citations (Scopus)

Abstract

Atherosclerosis of coronary arteries can result in a hypoxic state where myocardial cells may become dysfunctional or die. The oxygen sensing transcription factor hypoxia inducible factor 1 responds to low oxygen levels by elevating the production of angiogenic growth factors, such as vascular endothelial growth factor (VEGF). Despite this, endogenous processes and conventional therapies are inefficient in some patients. To stimulate angiogenesis, VEGF has been injected into the myocardium. As stated in this review, this therapy has so far been proven safe and studies are conducted in several countries, including Denmark.

Translated title of the contributionVascular endothelial growth factor therapy in ischaemic heart disease
Original languageDanish
JournalUgeskrift for Laeger
Volume182
Issue number44
ISSN0041-5782
Publication statusPublished - 26 Oct 2020

Fingerprint

Dive into the research topics of 'Vascular endothelial growth factor therapy in ischaemic heart disease'. Together they form a unique fingerprint.

Cite this